SEQH Capital Research

SEQH Capital Research

Market Brief + Model Portfolio Risk Assessment

11/4/25

SEQH Capital Research's avatar
SEQH Capital Research
Nov 04, 2025
∙ Paid

SEQH CAPITAL PARTNERS RESEARCH

MARKET TEAR SHEET | November 4, 2025

====================================================================

MARKET SNAPSHOT

Equity futures are pricing weakness this morning, with the S&P 500 down 1.3%, Nasdaq-100 off 1.6%, and Dow futures declining 1.0% (approximately 480 points). This pullback follows Monday’s mixed session where the S&P 500 gained 0.17% to close at 6,851.97, just 39 basis points below the October 28th all-time high of 6,890.89. The Nasdaq rose 0.46% to 23,834.72, driven primarily by Amazon’s record close following the $38 billion OpenAI partnership announcement.

The VIX has climbed to 18.06, up from 15.79 lows, signaling increased institutional hedging activity. This is a meaningful but not alarming move—still well below the 25+ panic threshold. The yield curve remains positive with 10-year Treasuries at 4.13% (up 14 bps week-over-week) and 2-year notes at 3.60%, creating a 53 basis point spread that supports equity valuations in a steady-state scenario.

Federal Reserve policy remains the critical variable. The FOMC cut rates 25 basis points on October 29th to 3.75%-4.00%, but Chair Powell’s language that a December cut is “far from foregone conclusion” has shifted market expectations. The CME FedWatch tool now assigns 67.3% probability to a December rate cut, down from 90% prior to Powell’s commentary. This repricing reflects divided committee positioning and concerns about sticky inflation.

====================================================================

TECHNICAL POSITIONING

S&P 500: 6,851.97 (November 3 close)

All-Time High: 6,890.89 (October 28)

Primary Support: 6,750 (gap fill zone)

Secondary Support: 6,500-6,550 (well-tested base)

Key Resistance: 6,890-6,900

The equal-weight index declined 1.75% for the week ending November 1st while the cap-weighted S&P gained 0.17%—a classic divergence signaling narrow leadership. The Magnificent Seven represents 35% of index market cap but drives 60%+ of earnings growth. This concentration creates stability on rallies but vulnerability on corrections.

Technical indicators suggest consolidation rather than capitulation. Bollinger Band signals remain active but not extreme. Put/call ratios are elevated, indicating hedging rather than panic. The 200-day moving average rests near 6,200, providing psychological support well below current levels.

The premarket weakness is noteworthy but not necessarily predictive. Morning trading often reverses by the cash open, particularly around earnings surprises. Watch for support to hold at 6,750 through this week’s earnings avalanche.

====================================================================

EARNINGS SEASON REALITY

Companies Reported (through Nov 1): 410 of 500 (82%)

EPS Beat Rate: 84% (vs. 72% five-year average)

Revenue Beat Rate: 76% (vs. 68% historical average)

Q3 EPS Growth (estimated): +10.7% (upgraded from 8.0% pre-season)

Q3 Revenue Growth (estimated): +4.2%

The beat rate exceeds expectations, but the composition matters. Technology and communication services drive 60% of total earnings growth, while other sectors show single-digit or negative growth. This explains why the S&P 500 shows strong YTD returns (+16.2%) while broader indices lag.

Key earnings this week include AMD (reporting after close today), which faces critical scrutiny following a 58% October gain. Palantir reported yesterday with a 63% revenue increase and 121% US Commercial segment growth, yet stock futures fell 4-7% premarket despite the beat. The divergence reflects valuation concerns: Palantir trades at 85x price-to-sales, Nvidia at 28x, and Broadcom at 12x. This dispersion creates opportunity for disciplined investors.

Forward P/E for the S&P 500 stands at 21.4x, a 27% premium to the 20-year average of 16.8x. Excluding the Magnificent Seven, the broader market trades at 16.2x with only 2.1% estimated growth—closer to historical medians but potentially indicating slower growth outside the AI complex.

====================================================================

MACROECONOMIC BACKDROP

ISM Manufacturing PMI (October): 48.7 (vs. 49.1 in September)

This marks the eighth consecutive month in contraction territory (below 50). The production subindex fell to 48.2, new orders at 49.4, and employment at 46.0. Only prices paid (58.0) showed meaningful deceleration from September’s elevated 61.9 reading.

This manufacturing weakness collides with strong earnings from technology and cloud infrastructure names. The divergence, deteriorating manufacturing alongside record technology earnings, is characteristic of a mid-cycle phase where leadership is narrow and rotation risk is elevated.

Labor Market Ambiguity: The government shutdown (day 35) has prevented release of September jobs data, forcing the Federal Reserve to operate “in the fog” of economic uncertainty. ADP data suggests 14,250 private jobs added weekly on average, but this represents a significant deceleration from August’s trend. Jobless claims remain historically low at approximately 220,000, conflicting with the manufacturing weakness signal.

Inflation Trajectory: Core PCE and CPI remain 2.4-2.5% above the 2% Fed target. Producer prices show limited deflation. The stickiness of inflation in this cycle argues for caution on aggressive December rate cut expectations. The October CPI release on November 12th will be critical data for Fed deliberations.

====================================================================

SECTOR PERFORMANCE & ALLOCATION

YTD Sector Returns (as of November 3):

Technology +23.4%

Communication Services +15.2%

Healthcare +14.8%

Consumer Discretionary +13.2%

Industrials +11.3%

Financials +6.7%

Consumer Staples +8.9%

Real Estate +4.2%

Utilities +3.1%

Energy -2.4%

November historically generates positive returns 75% of the time with an average gain of 1.8%. When October closes with positive returns (as occurred this year with S&P +2.3%), November success rate jumps to 92%. Healthcare sector exhibits an 80% November win rate, making defensive positioning appropriate if volatility extends.

Current sector dynamics show strength in technology and communication services reflecting AI enthusiasm, but deteriorating momentum in energy, utilities, and real estate reflects rate sensitivity and economic concerns. The narrow leadership suggests selective approach rather than broad market participation.

====================================================================

KEY METRICS & MACRO INDICATORS

Markets & Indices

S&P 500 Close 6,851.97 (+0.17%)

Nasdaq-100 Close 23,834.72 (+0.46%)

Dow Jones Close 26,784 (-0.08%)

YTD Returns: S&P +16.2% / Nasdaq +18.7% / Dow +13.9%

Fixed Income

10-Year Treasury 4.13% (+14 bps WoW)

2-Year Treasury 3.60% (+10 bps WoW)

30-Year Treasury 4.68% (+18 bps WoW)

Spread (10s-2s) 53 bps (positive curve)

Commodities & Currencies

Gold $3,997/oz (-0.3% WoW)

WTI Crude $60.10/bbl (-1.55%)

Bitcoin $107,929 (-3.2% WoW)

Dollar Index (DXY) 99.907 (+1.84 YoY)

Policy Environment

Fed Funds Target 3.75%-4.00% (-25 bps on Oct 29)

December Cut Probability 67.3% (-22.7% from 90%)

ISM Manufacturing PMI 48.7 (8 months in contraction)

====================================================================

CONVICTION IDEAS & TACTICAL TRADES

TIER 1

Broadcom (AVGO) | $1,850 | Target: $1,950-2,050

Holds 65% hyperscaler market share for custom AI accelerators, offering 3-5x better performance per watt than competitors at $15-20K lower cost. Stock has generated 8 consecutive quarter beats with 10-20% post-earnings moves. Q4 FY2025 earnings (December) should reflect significant new orders from hyperscalers. Strong risk/reward setup for accumulation on any 5-7% weakness.

Eli Lilly (LLY) | $920 | Target: $980-1,050

Dominant position in obesity and diabetes markets with 57% US incretin share versus Novo Nordisk. Q2 revenue reached $15.56B (+38% YoY) with Mounjaro at $5.2B (+68%) and Zepbound at $3.4B (+172%). Retatrutide pipeline trial results expected late 2025. Defensive healthcare exposure with growth characteristics; maintain 8% portfolio weight.

Amazon (AMZN) | $207 | Target: $210-230

$38B OpenAI partnership announced November 2nd secures hundreds of thousands of Nvidia GPUs for AWS infrastructure. AWS margin expansion continues with likely 35%+ target achievable by 2026. Trading at 32x forward P/E, reasonable valuation for cloud infrastructure dominance. Add on any premarket weakness in the $200-207 range.

TIER 2 - TACTICAL OPPORTUNITIES

Palantir (PLTR) | $197 | Target: $225-235

Q3 revenue of $1.181B (+63% YoY) and US Commercial segment of $397M (+121% YoY) clearly justify strong stock reaction. However, premarket down 4-7% on valuation concerns reflects 85x price-to-sales, highest in S&P 500. Q4 guidance of $1.329B (+61% YoY) and FY25 raise to $4.398B (+53%) indicate momentum persists. Buy dips to $190-195 zone; stop loss at $185. Valuation will compress as company scales; position sizing discipline critical.

Advanced Micro Devices (AMD) | $158 | Report Today After Close

October’s 58% gain warrants profit-taking, but recent wins (OpenAI, Oracle, DOE) position data center segment for acceleration. Key metrics: Q3 revenue trend, data center segment sustainability, gross margin progression. Needs beat and raise to justify further upside. Consider Jan 2026 $165 calls for leverage or buy any post-earnings weakness if guidance disappoints but fundamentals intact.

Energy Sector (XLE) | ~$82 | Target: $88-92 (6-month)

Oversold positioning with WTI crude at $60/bbl creates tactical rebound opportunity. Support holds at $80, resistance at $85. Catalysts include US-Venezuela tensions, China trade deal stimulus from November 1st agreement, winter heating demand, and OPEC+ meeting. 3-6 month holding period appropriate for portfolio diversification.

Applied Digital (APLD) | $28.50 | Target: $32-38

High-growth AI data center infrastructure benefiting from hyperscaler GPU hosting demand. Company remains unprofitable with significant CapEx requirements and execution risk, limiting position sizing to 1-2% portfolio maximum. Buy weakness to $26-27 zone; avoid chasing rallies above $30.

====================================================================

WEEK AHEAD: CRITICAL EVENTS

Tuesday, November 4

Pre-market Earnings: Pfizer, Uber, Spotify, BP, Ferrari, Shopify

After-market Earnings: AMD, Pinterest, Rivian, Cava, Super Micro

Economic Data: ADP Weekly Employment Report (only labor market data amid government shutdown)

Wednesday, November 5

ISM Services PMI (October; likely 50-52 range)

Trade Balance

Fed Speakers: Chicago Fed Evans, NY Fed Williams, Philadelphia Fed Harker

Earnings: 30+ additional S&P 500 companies

Thursday, November 6

Initial Jobless Claims (likely 218,000-225,000)

Productivity & Unit Labor Costs

Fed Speakers: Dallas Fed Kaplan, Atlanta Fed Bostic

Friday, November 8

University of Michigan Consumer Sentiment (preliminary; inflation expectations critical)

Weekly Options Expiration

====================================================================

====================================================================

BOTTOM LINE

The market enters November at a critical juncture. Strong AI earnings momentum confronts stretched valuations, seasonal strength conflicts with technical deterioration, and Fed rate cut hopes battle Powell hawkishness. Base case remains consolidation between 6,500 and 6,900 with increased tactical opportunities on 3-5% pullbacks.

The next 72 hours will test conviction with AMD earnings, Fed speaker guidance, and macroeconomic data points. Discipline and execution matter more than timing in this environment. Maintain selective exposure to AI infrastructure beneficiaries, rotate into defensive healthcare positioning, and preserve firepower for better entry points in quality compounders.

Support holding at 6,750 validates bullish seasonality. Any break below 6,500 warrants materially reduced exposure and increased hedge positioning. Watch for sector rotation into healthcare and industrials if technology weakness persists.

====================================================================

MODEL PORTFOLIO RISK ASSESSMENT (PRE-MARKET)

21-day parametric VaR, % on NAV

User's avatar

Continue reading this post for free, courtesy of SEQH Capital Research.

Or purchase a paid subscription.
© 2026 SEQH Capital Partners · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture